Evidence map›Paper›PMID 39579017›Full record

Trial reportInternational journal of cancer2025

Participation and relative cost of attendance by direct-mail compared to opt-in invitation strategy for HPV self-sampling targeting cervical screening non-attenders: A large-scale, randomized, pragmatic study.

Birgitte Tønnes Pedersen, Si Brask Sonne, Helle Pedersen, Emilie Korsgaard Andreasen, Reza Serizawa, Ditte Møller Ejegod, Jesper Bonde

Abstract readRandomized Controlled TrialPragmatic Clinical TrialComparative Study
In one paragraph

Trial report in International journal of cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Cervical cancer screening strategies in women 65 years and older in the human papillomavirus era: A systematic review and meta-analysis of human papillomavirus-based testing and self-sampling approaches.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Pooled it
  2. Trial
  3. Trial
  4. Mailing Vaginal or Urine Self-Sampling Kits versus Conventional Invitation Letters: A Randomized Trial to Assess the Effect on Cervical Cancer Screening Attendance.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Birgitte Tønnes PedersenDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Si Brask SonneDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Helle PedersenDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Emilie Korsgaard AndreasenDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Reza SerizawaDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Ditte Møller EjegodDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.
Jesper BondeDepartment of Pathology, Copenhagen University Hospital AHH-Hvidovre, Hvidovre, Denmark.ORCID 0000-0003-4853-6747

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Broad accessibility to cervical cancer screening and high participation rate is essential to reduce cervical cancer incidence. HPV self-sampling is an alternative to clinician collected cervical samples to increase accessibility and screening coverage. To inform on deployment strategies of HPV self-sampling, this large-scale, randomized, pragmatic study compared two invitation modalities; direct-mail and opt-in. The study included screening non-attenders from the Capital Region of Denmark randomly allocated (1:4) to a direct-mail or opt-in invitation for cervical screening by HPV self-sampling. Primary endpoint was screening participation; secondary endpoints were HPV prevalence and histology outcome. Adherence to follow-up and cost were also evaluated. After exclusion of hysterectomized/non-accessible women, 49,393 women were invited: 9639 by direct-mail, and 39,754 by the opt-in offer. A direct-mail invitation for HPV self-sampling yielded a significant higher participation than an opt-in invitation. HPV self-sample participation for direct-mail was 25.2% (n = 2426), opt-in participation was 20.2% (n = 8047), adjusted OR = 1.27, 95% CI 1.20-1.34. Participation increased with age (p < .0001) for both strategies and decreased with screening history of non-attendance (p < .0001). Interaction between invitation strategy and age/screening history was found; more women below 50 years of age participated by direct-mail compared to opt-in (p < .0001) and higher participation by direct-mail group was found in women with a short history of non-attendance (p < .0001). Participation of long-term unscreened women was similar between arms. The relative cost was ≈14 HPV self-sample kits distributed per additional participant by direct-mail over opt-in. HPV prevalence, adherence to follow-up, and detection of high-grade cervical intraepithelial neoplasia was similar between invitation strategies.

Indexed as

Early Detection of CancerPapillomavirus InfectionsPostal ServiceUterine Cervical NeoplasmsAdultAgedDenmarkFemaleHumansMass ScreeningMiddle AgedPapillomaviridaePatient Acceptance of Health CareSelf CareVaginal Smearscervical cancer preventioncervical cancer screeningHPVHPV self‐sampling

Identifiers

PMID39579017
PMCPMC11826108

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.